Lopes AM, Aston KI, Thompson E, Carvalho F, Gonçalves J, Huang N, Matthiesen R, Noordam MJ, Quintela I, Ramu A, Seabra C, Wilfert AB, et al. Human spermatogenic failure purges deleterious mutation load from the autosomes and both sex chromosomes, including the gene DMRT1. PLoS Genet 2013; 9(3):e1003349. The ovary is a miniature hormone factory, with the production of androgens and estrogens tightly controlled within each ovarian follicle. A new study suggests that an insulin-like peptide regulates androgen production in the follicles, a finding with implications for the understanding of a major cause of infertility, polycystic ovarian syndrome (PCOS).
Taming Androgens in the Ovary
Thecal cells, which surround the ovarian follicle, produce testosterone in response to stimulation by pituitary hormones. In turn, the granulosa cells that form the interior of the follicle and surround the oocyte convert androgens to estrogens. These hormones are necessary for numerous reproductive events, including preparing the uterus for implantation. Improper hormonal balance in the follicle can lead to health problems-for instance, overproduction of androgens is associated with PCOS.
Numerous factors that modulate androgen and estrogen production in the follicle have been identified, including bone morphogenic proteins (BMPs), which are widely expressed in the ovary and inhibit the production of androgens by thecal cells. The new findings by Philip Knight et al. suggest that BMPs in the bovine follicle act through insulin-like peptide 3 (INSL3) [1] .
The researchers found that BMP6, BMP2, BMP4, and BMP7, all known to be expressed in bovine follicles, have a major effect on INSL3 production in cultured bovine thecal cells. Addition of these BMPs to the cells quashed the expression of INSL3 and its receptor; reducing INSL3 levels using siRNA also reduced the expression of genes that control androgen production, whereas addition of INSL3 bumped up androgen production.
Whether the BMPs act directly through INSL3 or through another intermediary remains to be determined. But the findings jibe with another recent study by the same group, which shows that INSL3 levels peak during the pre-ovulatory phase of the bovine estrous cycle, when estrogen levels are high, and that INSL3 levels fall in sync with the decline in estrogen [2] .
Previous studies have shown that serum INSL3 levels are elevated in women with PCOS, supporting the possibility that an imbalance in INSL3 production contributes to the condition. A plasma protein produced in the liver, fetuin B, has a key role in fertilization of the mammalian oocyte: without the protein, the oocyte prematurely erects a barrier to sperm entry, leading to infertility [1] .
IVF researchers have long known that there are factors in serum that prevent hardening of the zona pellucida (ZP), the glycoprotein coat that surrounds the oocyte. ZP hardening occurs in response to fertilization and is set in motion by the actions of ovastacin, a protease that prompts the oocyte to release cortical granules, tiny sacks of proteases that cleave ZP glycoproteins and cause the ZP to harden (see [2] ). Hardening also occurs after ovulation in the absence of fertilization (about 30 hours afterward in mice), closing the time window for reproduction.
Fetuin A and B are liver-derived proteins in a family known to act as protease inhibitors; however, the physiological function of these proteins has been unclear. Fetuin A has previously been shown to prevent ZP hardening in vitro, but researchers have been stymied by the observation that mice deficient in fetuin A are fully fertile.
Eileen Dietzel and Jennifer Wessling et al. decided to take a closer look at fetuin B. First, they created mice deficient in this protein and found that the mice were infertile. The researchers then transplanted ovaries from fetuin B-deficient mice into wild-type mice and found that the transplant recipients were fertile.
Fetuin B, it seems, is able to enter follicular fluid from the blood. Experiments with human follicular fluid showed that fetuin-B is present in serum and follicular fluid in similar amounts. In vitro experiments with mouse oocytes indicated that fetuin B acts by inhibiting premature hardening of the ZP, apparently accomplishing this task by inhibiting ovastacin activity.
The findings have multiple implications. One next step is to test whether any of the numerous variants of fetuin B in the human population might affect fertility. As concerns in vitro fertilization (IVF), it is possible that addition of fetuin B to oocytes during IVF might improve success of the procedure in some patients.
A multitasking protein controls chromosomal activities during spermatogenesis in mice, according to a new report. The evolutionarily conserved protein, senataxin, is required for proper homologous recombination during meiosis and helps mediate the silencing of the XY body, which is restricted in a process called meiotic sex chromosome inactivation.
Studies in proliferating mammalian cells and yeast have suggested that senataxin may help co-ordinate replication, transcription, and DNA repair through multiple mechanisms. For instance, the yeast ortholog of senataxin is associated with DNA replication forks, and the mammalian protein binds to proteins involved in transcription. Moreover, senataxin seems to protect the genome from DNA damage by helping to eliminate R loops, RNA:DNA hybrids that form over transcription pause sites.
To further investigate the role of senataxin, Olivier Becherel et al. created mice deficient for this protein. The female mice had reduced fertility and the male mice were completely infertile. The researchers focused their studies on understanding the impairment in males.
The researchers found that in senataxin-deficient spermatocytes, R loops accumulated during meiotic recombination. Perhaps as a consequence of this defective R-loop elimination, DNA doublestranded breaks also accumulated, ultimately resulting in a failure of the essential step in meiosis, crossing over.
Proper formation of the XY body was also impaired. The XY body was transcriptionally active in senataxin-deficient mice, and proteins involved in XY silencing did not localize properly to the XY chromosomes. Senataxin was found to be associated with the XY body, a process that requires DNA repair protein BRCA1. As a result of these meiotic defects, spermatogenesis was arrested in the pachytene stage, resulting in apoptosis and male infertility.
The findings show how DNA-regulating proteins can be deployed for multiple tasks. Other examples include proteins involved in the response to DNA damage that also play essential roles in meiosis, such as BRCA1, MDC1, and H2AX. 
